Русский
Assessment of awareness of pre-exposure prophylaxis methods against HIV infection among healthcare specialists, medical students, and charitable foundation volunteers
DOI: https://dx.doi.org/10.18565/epidem.2022.12.3.54-8
Kuimova U.A., Belyaeva V.V., Kozyrina N.V., Kulabukhova E.I., Goliusova M.D., Kuimova I.V.
1) Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; 2) Peoples’ Friendship University of Russia, Moscow, Russia; 3) Novosibirsk State Medical University, Novosibirsk, Russia
Subjects and methods. The investigation involved respondents of 3 groups. Group 1 consisted of 73 healthcare workers; Group 2 included 75 five- and six-year medical students of faculties of pediatrics, general medicine, and medicine; Group 3 comprised of 26 volunteers of the «Shagi» (Steps) Regional Charitable Public AIDS Control Foundation. All the groups underwent a survey using the continuous sampling on the days of both face-to-face and Internet surveys.
Results. The mean HIV PrEP awareness self-assessment score was 5.36 in Group 1, 4.88 in Group 2, and 5.69 in Group 3. Group 1 respondents mainly received information about the method from scientific literature, in the learning process, and from the Internet (25.9, 22.2, and 12.9, respectively). Group 2 respondents did this in the process of learning, from the Internet, from scientific literature (42.4, 32.2, and 15.3%, respectively). The charitable foundation employees did this in the process of learning, from the Internet, from scientific literature (46,2, 36,6, and 15,4%, respectively). Respondents in this group mentioned PrEP more often when answering an indicator question about the HIV transmission prevention methods known to them (p < 0.05).
Conclusion. Poor self-awareness among the surveyed medical professionals, medical students, and non-profit organization employees is one of the main barriers to PrEP method use.
Literature
1. Holmes D. FDA paves the way for pre-exposure HIV prophylaxis. Lancet 2012; 380: 325. 2. Hodges-Mameletzis I., Dalal S., Msimanga-Radebe B., Rodolph M., Baggaley R. Going global: the adoption of the World Health Organization’s enabling recommendation on oral pre-exposure prophylaxis for HIV. Sex Health 2018; 15(6): 489–500. DOI: 10.1071/SH18125 3. Anderson P., Glidden D.V., Liu A., Buchbinder S., Lama J.R., Cuaniro J.. et al. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci. Transl. Med. 2012; 4(151): 151ra125. doi: 10.1126/scitranslmed.3004006 4. Molina J.M., Capitant С., Spire B., Pialoux G., Chidiac C., Charreau I. et al. On demand PrEP with oral TDF-FTC in MSM: results of the ANRS Ipergay trial. CROI 2015. 2015 Conference on Retroviruses and Opportunistic Infections (CROI 2015), 23–26 February 2015. Seattle, Washington, USA. Oral late breaker abstract 23LB. http://www.croiconference.org/ sessions/demand-prep-oral-tdf-ftc-msm-results-anrs-ipergay-trial 5. PrEP for HIV Prevention in the U.S. https://www.cdc.gov/nchhstp /newsroom/fact-sheets/hiv/PrEP-for-hiv-prevention-in-the-US-factsheet.html 6. FDA NEWS RELEASE. FDA Approves First Injectable Treatment for HIV Pre-Exposure Prevention https://www.fda.gov/news-events/press-announcements/fda-approves-first-injectable-treatment-hiv-pre-exposure-prevention 7. Ефремова О.С., Беляева В.В., Козырина Н.В., Куимова У.А., Покровская А.В., Суворова З.К. Оценка информированности ВИЧ-инфицированных пациентов о методике доконтактной профилактики, отношения к ее проведению и перспектив проведения в России. Эпидемиол. инфекц. болезни. Актуал. вопр. 2020; 10(3): 99–104. https://dx.doi.org/ 10.18565/epidem.2020.10.3.99-104 Efremova O.S., Belyaeva V.V., Kozyrina N.V., Kuimova U.A, Pokrovskaya A.V., Suvorova ZK. [Assessment of awareness about a pre-exposure prophylaxis procedure in HIV-infected patients, their attitude towards its implementation and prospects for its application]. Epidemiology and infectious deseases. Current items 2020; 10(3): 99–104. (In Russ.). https://dx.oi.org/10.18565/epidem.2020.10.3.99-104 8. Беляева В.В., Козырина Н.В., Куимова У.А., Голиусова М.Д., Ефремова О.С. Профилактика передачи ВИЧ в дискордантных парах: информированность, осознание риска, поведение. Инфекционные болезни: новости, мнения, обучение 2021; 10(1): 46–51. https://doi.org/10.33029/2305-3496-2021-10-1-46-51 Belyaeva V.V., Kozyrina N.V., Kuimova U.A., Goliusova M.D., Efremova O.S. [Prevention of transmission of HIV in discordant couples: awareness, risk perception, behaviour]. Infectious Diseases: News, Opinions, Training 2021; 10(1): 46–51. (In Russ.). DOI: https://doi.org/10.33029/2305-3496-2021-10-1-46-51.
About the Autors
Ulyana A. Kuimova, Cand. Med. Sci., Researcher, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; ulyanakuimova@gmail.com; http://orcid.org/0000-0002-1101-151X
Valentina V. Belyaeva, МD, Leading Researcher, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; labora-et-ora@yandex.ruORCID; http://orcid.org/0000-0002-4621-7892
Nadezhda V. Kozyrina, Cand. Med. Sci., Senior Researcher, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; nad-kozyrina@yandex.ru; htpp://orcid.org/0000-0001-5134-0054
Ekaterina I. Kulabukhova, Cand. Med. Sci., Infectiologist, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being; Head, Department of Infectious Diseases with Courses in Epidemiology and Phthisiology, Medical Institute, People’s Friendship University of Russia, Moscow, Russia, ekulabukhova@mail.ru; https://orcid.org/0000-0003-3645-7275
Marina D. Goliusova, Infectiologist, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia, mad2501@yandex.ru; https://orcid.org/ 0000-0002-5325-6857
Irina V. Kuimova, МD, Professor, Department of Infectious Diseases, Novosibirsk State Medical University, Novosibirsk, Russia, kuimova_ira@mail.ru; http://orcid.org/0000-0003-4727-1636
Similar Articles
